Invention Grant
- Patent Title: Compositions comprising urolithins and uses thereof for the stimulation of insulin secretion
-
Application No.: US15029384Application Date: 2014-10-15
-
Publication No.: US10583114B2Publication Date: 2020-03-10
- Inventor: Gerard Cros , Alan Crozier , Margherita Dall'asta , Daniele Del Rio , Richard Magous , Catherine Oiry
- Applicant: Centre National de la Recherche Scientifique (CNRS) , Universite de Montpellier , University of Parma , Ecole Nationale Superieure de Chimie
- Applicant Address: FR Paris FR Montpellier IT Parma FR Montpellier FR Paris FR Montpellier
- Assignee: Centre National de la Recherche Scientifique (CNRS),Universite de Montpellier,University of Parma,Ecole Nationale Superieure de Chimie,Centre National de la Recherche Scientifique,Universite de Montpellier
- Current Assignee: Centre National de la Recherche Scientifique (CNRS),Universite de Montpellier,University of Parma,Ecole Nationale Superieure de Chimie,Centre National de la Recherche Scientifique,Universite de Montpellier
- Current Assignee Address: FR Paris FR Montpellier IT Parma FR Montpellier FR Paris FR Montpellier
- Agency: Buchanan Ingersoll & Rooney PC
- Priority: EP13306415 20131015
- International Application: PCT/EP2014/072152 WO 20141015
- International Announcement: WO2015/055736 WO 20150423
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61K31/37 ; A61K31/255
Abstract:
The present invention relates to a composition comprising urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, for the stimulation of insulin secretion, and to the use of a compound chosen among urolithin A, urolithin B, urolithin C, urolithin D, or a combination thereof, intended for the stimulation of insulin secretion. The present invention also relates to a composition comprising an effective amount of urolithin B, urolithin C, urolithin D, or a combination thereof, for the treatment or the prevention of diabetes mellitus, and in particular for the treatment or the prevention of type 2 diabetes, and to the use of a compound chosen among urolithin B, urolithin C, urolithin D, and a combination thereof, intended for the treatment or the prevention of diabetes mellitus, and in particular of type 2 diabetes.
Public/Granted literature
- US20160279097A1 COMPOSITIONS COMPRISING UROLITHINS AND USES THEREOF FOR THE STIMULATION OF INSULIN SECRETION Public/Granted day:2016-09-29
Information query
IPC分类:
